论文信息 - Multicenter, randomized phase II trial of GM-CSF (GM) plus ipilimumab (Ipi) versus Ipi alone in metastatic melanoma: E1608. - 字舞流文

Multicenter, randomized phase II trial of GM-CSF (GM) plus ipilimumab (Ipi) versus Ipi alone in metastatic melanoma: E1608.

J. Kirkwood | L. Butterfield | I. Puzanov | U. Rao | D. McDermott | P. Leming | A. Tarhini | Sandra J. Lee